STAA
STAAR SURGICAL COCompany Information
- Company Name
- STAAR SURGICAL CO
- CIK
- CIK0000718937
- Category
- Large accelerated filer
- Ticker: Exchange
- STAA: Nasdaq
- Fiscal Year End
- January 02
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3851
- SIC Description
- Ophthalmic Goods
- Ticker
- STAA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-13
- Last sale
- 2023-03-17
- Shares purchased (TTM)
- 1,466,109
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 55,319,291
- Shares outstanding
- 50,321,000
- Ownership
- 109.93%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -7.63%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 149 | 132 | 153 | 176 | 167 | 173 | 144 | 164 | 193 | 224 | 183 | 127 | ||||||
| Short Term Investments | 33 | 32 | 34 | 17 | 23 | 50 | 86 | 72 | 42 | 21 | 38 | 61 | ||||||
| Accounts Receivable Net Current | 98 | 81 | 50 | 60 | 34 | 40 | 78 | 105 | 94 | 65 | 95 | 112 | ||||||
| F I F O Inventory Amount | 47 | 50 | 55 | 53 | 53 | 48 | 43 | 40 | 39 | 39 | 35 | 31 | ||||||
| Assets Current | 342 | 312 | 312 | 321 | 293 | 326 | 368 | 397 | 384 | 366 | 365 | 347 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | - | 0 | 7 | 12 | 14 | ||||||
| Property Plant And Equipment Net | 70 | 72 | 73 | 73 | 74 | 75 | 85 | 82 | 78 | 72 | 67 | 63 | ||||||
| Finance Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 28 | 29 | 30 | 31 | 33 | 31 | 37 | 38 | 35 | 35 | 34 | 35 | ||||||
| Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | 1 | 1 | 3 | 2 | 12 | 4 | 1 | 5 | 5 | 5 | 5 | 9 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 27 | 24 | 19 | 1 | 14 | 9 | 6 | 3 | 2 | ||||||
| Assets | 475 | 451 | 452 | 456 | 438 | 457 | 510 | 538 | 513 | 493 | 489 | 472 | ||||||
Liabilities | ||||||||||||||||||
| Accounts Payable Current | 13 | 9 | 12 | 9 | 12 | 11 | 17 | 15 | 19 | 17 | 14 | 9 | ||||||
| Finance Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 6 | 6 | 6 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 4 | 4 | ||||||
| Other Liabilities Current | 38 | 33 | 41 | 40 | 37 | 48 | 43 | 39 | 35 | 35 | 41 | 36 | ||||||
| Liabilities Current | 73 | 61 | 69 | 62 | 59 | 68 | 70 | 66 | 66 | 63 | 65 | 57 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 30 | 31 | 32 | 34 | 35 | 33 | 35 | 35 | 31 | 31 | 31 | 32 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Asset Retirement Obligations Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Rent Credit Noncurrent | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Defined Benefit Pension Plan Liabilities Noncurrent | 7 | 6 | 6 | 7 | 7 | 6 | 7 | 7 | 5 | 5 | 5 | 3 | ||||||
| Liabilities | 110 | 99 | 107 | 103 | 101 | 107 | 112 | 109 | 104 | 100 | 103 | 93 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 513 | 508 | 505 | 496 | 485 | 477 | 471 | 467 | 457 | 448 | 437 | 436 | ||||||
| Treasury Stock Value | -6 | -6 | -6 | -6 | -4 | - | - | - | - | - | - | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -7 | -7 | -7 | -7 | -6 | -6 | -7 | -6 | -5 | -5 | -4 | -3 | ||||||
| Retained Earnings Accumulated Deficit | -135 | -143 | -148 | -130 | -139 | -122 | -68 | -33 | -43 | -51 | -47 | -55 | ||||||
| Stockholders Equity | 365 | 352 | 344 | 354 | 337 | 350 | 397 | 428 | 409 | 393 | 386 | 379 | ||||||
| Liabilities And Stockholders Equity | 475 | 451 | 452 | 456 | 438 | 457 | 510 | 538 | 513 | 493 | 489 | 472 | ||||||
| Debt Securities Available For Sale Amortized Cost Current | 33 | 32 | 34 | 17 | 23 | 50 | 86 | - | - | - | 38 | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Debt Securities Available For Sale Amortized Cost Noncurrent | - | - | - | - | - | - | - | - | - | - | 12 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | ||||||
| Common Stock Shares Issued | 50 | 50 | 50 | 50 | 50 | 50 | 49 | 49 | 49 | 49 | 49 | 49 | ||||||
| Shares Outstanding | 50 | 50 | 49 | 50 | 50 | 50 | 49 | 49 | 49 | 49 | 49 | 49 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSTAAR SURGICAL CO (STAA) — SEC Financial Statements & Analysis
STAAR SURGICAL CO (STAA) is a ophthalmic goods company, incorporated in DE. STAAR SURGICAL CO trades on Nasdaq as: STAA. STAAR SURGICAL CO (STAA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, STAAR SURGICAL CO carries a market cap of $1.44B, a P/E ratio of 376.06x, a P/B ratio of 3.95x, a P/S ratio of 4.25x, an enterprise value of $1.30B, and an EV/EBITDA multiple of 58.24x. On profitability, it posts a gross margin of 76.62%, an operating margin of 4.04%, a net margin of 1.13%, a Return on Equity (ROE) of 1.09%, a Return on Assets (ROA) of 0.84%, and a Return on Invested Capital (ROIC) of 1.53%. Per share, it reports EPS of $0.08, diluted EPS of $0.07, free cash flow per share of $-0.13, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 51.30% year-over-year, net income growth of -104.03% year-over-year, and EPS growth of -103.97% year-over-year. On the balance sheet, it maintains a current ratio of 4.66x, a quick ratio of 4.66x, working capital of $268.96M, a debt-to-equity ratio of 0.30x, a debt ratio of 0.23, an interest coverage ratio of 3.70x, free cash flow of $-6.75M (TTM), and net debt of $-148.58M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.44B
- P/E TTM
- 376.06x
- EPS TTM
- $0.08
- P/B TTM
- 3.95x
- ROE TTM
- 1.09%
- ROA TTM
- 0.84%
- Debt To Equity
- 0.30x
- Free Cash Flow TTM
- $-6.75M
- Net Revenue TTM Growth 1Y
- 51.30%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is STAAR SURGICAL CO in?
STAAR SURGICAL CO (STAA) operates in the Ophthalmic Goods industry.
What exchange does STAA trade on?
STAAR SURGICAL CO (STAA) trades on the Nasdaq.
Where is STAAR SURGICAL CO incorporated?
STAAR SURGICAL CO is incorporated in DE.
When was STAAR SURGICAL CO (STAA)'s most recent SEC filing?
STAAR SURGICAL CO (STAA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is STAA's market cap?
STAAR SURGICAL CO (STAA) has a market capitalization of $1.44B as of 2026-06-30.
What is STAA's P/E ratio?
STAAR SURGICAL CO (STAA)'s trailing twelve month P/E ratio is 376.06x as of 2026-06-30.
What is STAA's EPS (earnings per share)?
STAAR SURGICAL CO (STAA)'s trailing twelve month EPS is $0.08 as of 2026-06-30.
What is STAA's ROE (return on equity)?
STAAR SURGICAL CO (STAA)'s trailing twelve month Return on Equity (ROE) is 1.09% as of 2026-06-30.
What is STAA's ROA (return on assets)?
STAAR SURGICAL CO (STAA)'s trailing twelve month Return on Assets (ROA) is 0.84% as of 2026-06-30.
What is STAA's ROIC (return on invested capital)?
STAAR SURGICAL CO (STAA)'s trailing twelve month Return on Invested Capital (ROIC) is 1.53% as of 2026-06-30.
What is STAA's EV/EBITDA?
STAAR SURGICAL CO (STAA)'s trailing twelve month EV/EBITDA is 58.24x as of 2026-06-30.